Home/Publication/InvAscent Completes Exit from CDMO Stericon Pharma
InvAscent Completes Exit from CDMO Stericon Pharma 

06 Apr 2023

US$ 19.00

InvAscent has concluded its investment in Stericon Pharma Pvt Ltd (Stericon Pharma) which will be acquired...

Price / article: US$19.00
OR existing subscriber
Related Publications

KKR & Co Inc (KKR) has disposed of an additional 9.5% stake in Korea-listed HD Hyundai Marine Solution Co Ltd (Hyundai...

Quadria Capital closed its Quadria Capital Fund III LP (Quadria III) at US$1.07 bn, having enlisted Asian ......

Connect With Us

We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.

Rest assured that your email address will not be shared, as we hate spams as much as you do.